title: The disruption of hepatic cytochrome p450 reductase alters mouse lipid metabolism.
abstract: To elucidate the role of hepatic cytochrome P450 oxidoreductase (POR) in lipid metabolism, we characterized perturbations in lipid homeostasis in a mouse model deficient in liver POR. Using an integrative approach in which transcriptomics, lipidomics, and various bioinformatic algorithms were employed, a disruption in liver lipid mobilization, oxidation, and electron transport functions were identified. Analyzing the promoters of genes in these biological processes identified common binding motifs for nuclear receptors sensitive to lipid status, while Srebp-1c binding sites were only identified in genes involved in lipid metabolism. POR-null mice had drastic increases in hepatic lipid content (diacylglycerols, triacylglycerols, phosphatidylcholine, and cholesterol esters) and a specific enrichment in n-7 and n-9 monounsaturated fatty acids (FAs). It was found that while transporters involved in peroxisomal FA oxidation were induced, mitochondrial oxidation appeared to be more tightly controlled, supporting the increase in monounsaturated FAs. Genes coding for hepatic transporters were differentially expressed, where lipid uptake was induced and efflux repressed, indicating that in the absence of hepatic POR the liver serves as a lipid reservoir. Furthermore, while significant changes in intestinal gene expression were found in POR-deficient mice, only minor changes to plasma and intestinal lipid content were observed. Thus, while liver POR plays an important role regulating gene expression and lipid metabolism locally, the hepatic deficiency of this enzyme reverberates throughout the biological system and produces a coordinated response to the low levels of circulating cholesterol and bile.
authors.affiliation: Nestlé Research Center, Vers-chez-les-Blanc, CH-1000 Lausanne 26, Switzerland. dmmutch_sci@hotmail.com
authors.forename: David M
authors.initials: DM
authors.lastname: Mutch
authors.forename: Bernward
authors.initials: B
authors.lastname: Klocke
authors.forename: Peter
authors.initials: P
authors.lastname: Morrison
authors.forename: Carol A
authors.initials: CA
authors.lastname: Murray
authors.forename: Colin J
authors.initials: CJ
authors.lastname: Henderson
authors.forename: Martin
authors.initials: M
authors.lastname: Seifert
authors.forename: Gary
authors.initials: G
authors.lastname: Williamson
mesh_terms: D000818:Animals; D001647:Bile Acids and Salts / Q000378:metabolism; D002784:Cholesterol / Q000097:blood / Q000378:metabolism; D005227:Fatty Acids / Q000097:blood / Q000378:metabolism; D020869:Gene Expression Profiling; D005989:Glycerides / Q000097:blood / Q000378:metabolism; D007413:Intestinal Mucosa / Q000378:metabolism; D007583:Jejunum / Q000378:metabolism; D050356:Lipid Metabolism; D008099:Liver / Q000201:enzymology / Q000378:metabolism*; D051379:Mice; D008810:Mice, Inbred C57BL; D008819:Mice, Nude; D009251:NADPH-Ferrihemoprotein Reductase / Q000235:genetics / Q000502:physiology*; D009928:Organ Specificity; D010713:Phosphatidylcholines / Q000097:blood / Q000378:metabolism; D010714:Phosphatidylethanolamines / Q000097:blood / Q000378:metabolism
chemical_list: D001647:Bile Acids and Salts; D005227:Fatty Acids; D005989:Glycerides; D010713:Phosphatidylcholines; D010714:Phosphatidylethanolamines; D002784:Cholesterol; D009251:NADPH-Ferrihemoprotein Reductase